These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11847536)

  • 41. No effect of gender or age on binding characteristics of valproic acid to serum proteins in pediatric patients with epilepsy.
    Kodama Y; Kodama H; Kuranari M; Tsutsumi K; Ono S; Fujimura A
    J Clin Pharmacol; 1999 Oct; 39(10):1070-6. PubMed ID: 10516942
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vivo binding characteristics of phenytoin to serum proteins in monotherapy for adults with epilepsy.
    Kodama H; Kodama Y; Shinozawa S; Kanemaru R; Todaka K; Mitsuyama Y
    Am J Ther; 2000 Nov; 7(6):359-63. PubMed ID: 11304643
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lack of an effect of valproate concentration on lamotrigine pharmacokinetics in developmentally disabled patients with epilepsy.
    Gidal BE; Anderson GD; Rutecki PR; Shaw R; Lanning A
    Epilepsy Res; 2000 Nov; 42(1):23-31. PubMed ID: 10996503
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protein binding of valproic acid in Japanese pediatric and adult patients with epilepsy.
    Kodama Y; Kodama H; Kuranari M; Tsutsumi K; Ono S; Yamaguchi T; Fujimura A
    Am J Health Syst Pharm; 2002 May; 59(9):835-40. PubMed ID: 12004461
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relationship between serum concentration and dose of valproic acid during monotherapy in adult outpatients.
    Tisdale JE; Tsuyuki RT; Oles KS; Penry JK
    Ther Drug Monit; 1992 Oct; 14(5):416-23. PubMed ID: 1448851
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics of total and free valproic acid during monotherapy in infants.
    Herngren L; Lundberg B; Nergårdh A
    J Neurol; 1991 Sep; 238(6):315-9. PubMed ID: 1940980
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Valproate unbound fraction and distribution volume following rapid infusions in patients with epilepsy.
    Cloyd JC; Dutta S; Cao G; Walch JK; Collins SD; Granneman GR;
    Epilepsy Res; 2003 Feb; 53(1-2):19-27. PubMed ID: 12576164
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of age and polytherapy, risk factors of valproic acid (VPA) hepatotoxicity, on the excretion of thiol conjugates of (E)-2,4-diene VPA in people with epilepsy taking VPA.
    Gopaul S; Farrell K; Abbott F
    Epilepsia; 2003 Mar; 44(3):322-8. PubMed ID: 12614387
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Indirect estimation of the unbound fraction of cyclosporine in plasma.
    Akhlaghi F; Ashley JJ; Keogh AM; Brown KF
    Ther Drug Monit; 1998 Jun; 20(3):301-8. PubMed ID: 9631927
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A population pharmacokinetic model of valproic acid in pediatric patients with epilepsy: a non-linear pharmacokinetic model based on protein-binding saturation.
    Ding J; Wang Y; Lin W; Wang C; Zhao L; Li X; Zhao Z; Miao L; Jiao Z
    Clin Pharmacokinet; 2015 Mar; 54(3):305-17. PubMed ID: 25388986
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nutritional influence on serum ammonia in young patients receiving sodium valproate.
    Laub MC
    Epilepsia; 1986; 27(1):55-9. PubMed ID: 3081337
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Blood ammonia level during valproic acid therapy.
    Kugoh T; Yamamoto M; Hosokawa K
    Jpn J Psychiatry Neurol; 1986 Dec; 40(4):663-8. PubMed ID: 3110472
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Valproic acid and thrombocytopenia in children: a case-controlled retrospective study.
    Allarakhia IN; Garofalo EA; Komarynski MA; Robertson PL
    Pediatr Neurol; 1996 May; 14(4):303-7. PubMed ID: 8805173
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Australian brain and cognition and antiepileptic drugs study: IQ in school-aged children exposed to sodium valproate and polytherapy.
    Nadebaum C; Anderson V; Vajda F; Reutens D; Barton S; Wood A
    J Int Neuropsychol Soc; 2011 Jan; 17(1):133-42. PubMed ID: 21092354
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The influence of old age and enzyme inducing comedication on the pharmacokinetics of valproic acid at steady-state: A case-matched evaluation based on therapeutic drug monitoring data.
    Fattore C; Messina S; Battino D; Croci D; Mamoli D; Perucca E
    Epilepsy Res; 2006 Aug; 70(2-3):153-60. PubMed ID: 16730950
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of a Simple and Rapid Method to Measure Free Fraction of Valproic Acid in Plasma Using Ultrafiltration and Ultra High Performance Liquid Chromatography-Mass Spectroscopy: Application to Therapeutic Drug Monitoring.
    Xu S; Chen Y; Zhao M; Zhao L
    Ther Drug Monit; 2017 Oct; 39(5):575-579. PubMed ID: 28700449
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic polymorphisms and valproic acid plasma concentration in children with epilepsy on valproic acid monotherapy.
    Mei S; Feng W; Zhu L; Yu Y; Yang W; Gao B; Wu X; Zhao Z; Fang F
    Seizure; 2017 Oct; 51():22-26. PubMed ID: 28763744
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preliminary results on pregnancy outcomes in women using lamotrigine.
    Tennis P; Eldridge RR;
    Epilepsia; 2002 Oct; 43(10):1161-7. PubMed ID: 12366730
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Performance of two predictive methods for calculation of the key pharmacokinetic parameters for gentamicin dosage individualization.
    el-Sayed YM
    J Clin Pharm Ther; 1989 Apr; 14(2):119-26. PubMed ID: 2722975
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Valproic acid clearance in children with epilepsy.
    Sánchez-Alcaraz A; Quintana MB; López E; Rodríguez I
    J Clin Pharm Ther; 1998 Feb; 23(1):31-4. PubMed ID: 9756109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.